MSD pharma likely to participate when govt floats tender for vaccine against cervical cancer
The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, was launched last month. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII), wrote a letter to the Health Ministry recently, saying its first indigenous HPV vaccine will be available in the private market at an MRP of Rs 2,000 per dose, it has been learnt. CERVAVAC will be available in two-dose glass vial presentation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 15, 2023 Category: Pharmaceuticals Source Type: news

Can PET/CT scans replace bone biopsies in lymphoma patients?
FDG-PET/CT scans may be preferred over invasive biopsies for detecting bon...Read more on AuntMinnie.comRelated Reading: PET tracer uptake related to COVID-19 vaccines detected in lymphoma patients PET/MRI an effective alternative to PET/CT for lymphoma management AI increases PET/CT reporting efficiency in lymphoma staging PET/CT can reduce mediastinal cancer biopsies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 14, 2023 Category: Radiology Source Type: news

Janssen Data at ASCO GU Support Ambition to Transform Treatment of Prostate and Bladder Cancer Through Precision Medicine and Early Intervention
RARITAN, N.J., February 13, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced plans to present more than 20 abstracts featuring seven oncology therapies from its robust portfolio and pipeline at the annual American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, taking place in San Francisco on February 16-18. Building on more than a decade of leadership in the development of medicines for people diagnosed with GU cancers, Janssen will present data demonstrating its ambition to advance patient-centered treatment through precision medicine, real-world evidence a...
Source: Johnson and Johnson - February 13, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

Vaccination of girls against cervical cancer likely to begin in six states in June: Sources
The Union Health Ministry has drawn a roadmap to roll out HPV vaccine in the universal immunisation programme and is likely to float a global tender in April for 16.02 crore doses to be procured by 2026, official sources said. (Source: The Economic Times)
Source: The Economic Times - February 12, 2023 Category: Consumer Health News Source Type: news

PFAS ‘ Forever Chemicals ’ Are Turning Up in Menstrual Products. Here ’ s What You Need to Know
Feminine hygiene products may be among the most basic and essential purchases a consumer can make. The 72 million women and girls in the U.S. of child bearing age—broadly defined as ages 15 to 49—rely on industry to provide them a diverse range of sanitary products, from tampons to pads to period underwear to liners, and industry generally responds. But increasingly it seems that manufacturers are delivering these consumers a very bad thing as well—one that can pose a grave threat to their health and welfare. Over the past three years, feminine hygiene products have been turning up contaminated by PFAS, s...
Source: TIME: Health - February 9, 2023 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized Explainer healthscienceclimate Wellbeing Source Type: news